Diagnostic testing for rabies, mpox and several other infectious diseases at the federal public health agency has been placed on hold. The pause affects confirmatory assays run by the Centers for Disease Control and Prevention that support state and local laboratories.
The suspension involves polymerase chain reaction testing and serologic analysis that help identify viral exposure and guide post exposure prophylaxis. State health departments often rely on these reference tests to validate local results, track transmission chains and feed data into national surveillance systems used for risk assessment.
Public health officials are reviewing laboratory workflows, quality control procedures and biosafety protocols, according to internal summaries cited by multiple media outlets. The pause disrupts routine submission of clinical specimens, including brain tissue from animals suspected of carrying rabies and lesion swabs from suspected mpox cases, which are normally routed to federal laboratories.
Epidemiologists warn that gaps in centralized confirmatory testing can delay case classification, contact tracing and allocation of vaccines or immunoglobulin used in rabies prophylaxis. Laboratory capacity, data interoperability and the basic reproduction number of circulating pathogens remain central variables as health agencies adjust their surveillance architecture.
